Ganciclovir use during mild renal failure in heart transplantation.
Bastien
O
O
Hôpital Cardiologique et Pneumologique L. Pradel, Lyon, France.
Boulieu
R
R
Bleyzac
N
N
Boissonnat
P
P
Garre
J P
JP
Dureau
G
G
D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016009:Chi-Square Distribution; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D015774:Ganciclovir / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016027:Heart Transplantation / Q000502:physiology; D006801:Humans; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011183:Postoperative Complications; D051437:Renal Insufficiency / Q000097:blood / Q000503:physiopathology*
D000998:Antiviral Agents; D015774:Ganciclovir